Skip to content

NVCTNUVECTIS PHARMA INC

CUSIP 67080T108 · common stock

1 tracked investor held NUVECTIS PHARMA INC (NVCT) at the end of Q3 2026, worth $5.1M. The largest holder was Perceptive Advisors, with 0.1% of its portfolio.

Holders · Q3 2026
1
New holders
0
Value held
$5.1M
Quarter-end price (est.)
$21.12

Investors holding NVCT · Q3 2026

InvestorWeightSharesValueChange
Perceptive Advisors
Perceptive Advisors LLC
0.09%240,000$5.1MREDUCE-76.0%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026100$5.1M$21.12
Q2 2026110$18.4M$18.39